Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial

This study has been completed.
Makerere University
University of Toronto
Information provided by (Responsible Party):
University Health Network, Toronto Identifier:
First received: December 5, 2010
Last updated: February 19, 2014
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by Identifier (NCT Number):